Prenatal diagnostic: The rise of exome sequencing

Prenatal diagnostic testing is no longer limited to ultrasounds and chromosomal karyotyping. In recent years, genomic technologies have transformed prenatal care, allowing clinicians to move beyond structural imaging into the realm of molecular precision. Among these tools, exome sequencing stands out for its ability to uncover the genetic causes of fetal anomalies, especially when conventional tests come back inconclusive.

In this article, we explore how exome sequencing fits into the modern prenatal diagnostic toolbox, when it’s recommended, and why every healthcare professional working in maternal-fetal medicine should understand it.

What is prenatal diagnostic testing?

Prenatal diagnostic testing refers to a range of procedures used to detect fetal abnormalities during pregnancy. Traditionally, this includes ultrasounds for anatomical anomalies, karyotyping for chromosomal abnormalities, prenatal blood tests including cell-free DNA (cfDNA) and biochemical markers, and procedures like chorionic villus sampling (CVS) or amniocentesis for genetic analysis.

These methods remain essential. However, they often fail to provide answers in cases with non-specific anomalies or multiple congenital malformations. This is where genetic prenatal testing, especially exome sequencing, comes into play.

When is prenatal exome sequencing indicated?

Prenatal exome sequencing, or pES, is most often indicated in high-risk pregnancies. Common examples include increased nuchal translucency with a normal microarray, multiple structural abnormalities detected via ultrasound, a family history of genetic disorders, or recurrent pregnancy loss without clear etiology.

It’s not a first-line test, but rather a second-tier diagnostic tool when conventional methods leave uncertainty.

In studies, pES has shown a diagnostic yield of up to 40% in selected cases. That’s not just data, it’s peace of mind for patients and clinical direction for providers.

What makes exome sequencing different?

Unlike standard prenatal DNA testing, which looks for known chromosomal alterations, exome sequencing analyzes all protein-coding regions of the genome. These regions, though they make up only 1 to 2 percent of the genome, account for about 85 percent of disease-causing mutations.

This allows clinicians to detect rare de novo mutations, identify recessive disorders in consanguineous couples, and provide more accurate prognoses for parents and neonatologists.

Of course, this also requires robust bioinformatics pipelines and expert interpretation, especially when dealing with variants of uncertain significance.

The challenge of uncertain findings

One of the most critical steps in prenatal exome sequencing is interpreting the results. What does a variant of uncertain significance mean for this specific fetus? Should secondary findings be disclosed prenatally? How do we communicate uncertainty without overwhelming parents?

These are not just scientific questions, they are ethical dilemmas. Tools like ACMG guidelines and curated variant databases help, but they don’t replace clinical judgment.

Why genetic counseling is key

Pre- and post-test counseling is essential. Before initiating exome sequencing, parents must understand what the test can and cannot reveal, the possibility of uncertain or incidental findings, and how results may impact decisions about pregnancy and delivery.

It’s not just about genetics, it’s about navigating complexity with compassion.

Clinical case insight, when answers matter most

In real world practice, exome sequencing can be the difference between diagnostic dead-end and actionable insight. Consider a case where multiple anomalies are found but microarray results are normal. Exome sequencing reveals a de novo pathogenic variant in a gene associated with neurodevelopmental syndromes, offering both clarity and direction.

Ready to deepen your knowledge?

Exome sequencing is becoming a crucial tool in prenatal diagnostics. Understanding when and how to use it responsibly is no longer optional.

Enroll now in our UEMS accredited course on Prenatal Exome Sequencing.
Dive into real clinical cases, interpretation strategies, and counseling approaches, on demand, with CME or CPD credits. Available for free on Xpeer.